Annual Retained Earnings
-$158.25 M
-$1.78 M-1.14%
December 31, 2023
Summary
- As of February 6, 2025, XTLB annual retained earnings is -$158.25 million, with the most recent change of -$1.78 million (-1.14%) on December 31, 2023.
- During the last 3 years, XTLB annual retained earnings has fallen by -$2.64 million (-1.70%).
- XTLB annual retained earnings is now -128.34% below its all-time high of -$69.30 million, reached on December 31, 2003.
Performance
XTLB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$158.77 M
-$533.00 K-0.34%
September 30, 2024
Summary
- As of February 6, 2025, XTLB quarterly retained earnings is -$158.77 million, with the most recent change of -$533.00 thousand (-0.34%) on September 30, 2024.
- Over the past year, XTLB quarterly retained earnings has dropped by -$1.00 million (-0.64%).
- XTLB quarterly retained earnings is now -100.03% below its all-time high of -$79.37 million, reached on June 30, 2004.
Performance
XTLB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
XTLB Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | -0.6% |
| 3 y3 years | -1.7% | -0.6% |
| 5 y5 years | -4.2% | - |
XTLB Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.0% | at low | -2.5% | at low |
| 5 y | 5-year | -3.6% | at low | -4.0% | at low |
| alltime | all time | -128.3% | at low | -100.0% | at low |
XTL Biopharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$158.77 M(+0.3%) |
| Jun 2024 | - | -$158.23 M(+0.3%) |
| Mar 2024 | - | -$157.76 M(-0.3%) |
| Dec 2023 | -$158.25 M(+1.1%) | -$158.25 M(+0.2%) |
| Sep 2023 | - | -$157.97 M(+0.1%) |
| Jun 2023 | - | -$157.75 M(+0.2%) |
| Mar 2023 | - | -$157.38 M(+0.6%) |
| Dec 2022 | -$156.47 M(+0.9%) | -$156.47 M(+0.5%) |
| Sep 2022 | - | -$155.72 M(+0.5%) |
| Jun 2022 | - | -$154.90 M(-0.1%) |
| Dec 2021 | -$155.13 M(-0.3%) | -$155.13 M(-0.8%) |
| Jun 2021 | - | -$156.45 M(+0.5%) |
| Dec 2020 | -$155.60 M(+1.9%) | -$155.60 M(+1.9%) |
| Dec 2019 | -$152.70 M(+0.5%) | -$152.70 M(+0.5%) |
| Dec 2018 | -$151.94 M(-2.4%) | -$151.94 M(-2.4%) |
| Dec 2017 | -$155.65 M(+0.5%) | -$155.65 M(-0.0%) |
| Sep 2017 | - | -$155.65 M(-1.0%) |
| Jun 2017 | - | -$157.24 M(+1.5%) |
| Dec 2016 | -$154.90 M(+1.6%) | -$154.90 M(+0.9%) |
| Jun 2016 | - | -$153.46 M(+0.6%) |
| Dec 2015 | -$152.49 M(+2.8%) | -$152.49 M(+1.6%) |
| Sep 2015 | - | -$150.15 M(+0.3%) |
| Jun 2015 | - | -$149.74 M(+1.0%) |
| Dec 2014 | -$148.32 M | -$148.32 M(+0.5%) |
| Sep 2014 | - | -$147.59 M(+0.3%) |
| Jun 2014 | - | -$147.13 M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -$146.63 M(+0.4%) |
| Dec 2013 | -$146.07 M(+1.8%) | -$146.07 M(+0.9%) |
| Sep 2013 | - | -$144.77 M(-0.1%) |
| Jun 2013 | - | -$144.94 M(+0.5%) |
| Mar 2013 | - | -$144.15 M(+0.4%) |
| Dec 2012 | -$143.56 M(+2.6%) | -$143.56 M(-0.0%) |
| Sep 2012 | - | -$143.60 M(-0.3%) |
| Jun 2012 | - | -$144.02 M(+0.3%) |
| Mar 2012 | - | -$143.61 M(+0.4%) |
| Sep 2011 | - | -$143.00 M(+0.2%) |
| Jun 2011 | - | -$142.68 M(+0.2%) |
| Mar 2011 | - | -$142.42 M(+0.4%) |
| Sep 2010 | - | -$141.86 M(+0.1%) |
| Jun 2010 | - | -$141.72 M(+0.2%) |
| Mar 2010 | - | -$141.45 M(+0.3%) |
| Sep 2009 | - | -$140.99 M(-4.1%) |
| Jun 2008 | - | -$146.98 M(+5.1%) |
| Dec 2007 | -$139.86 M(+21.7%) | -$139.86 M(+7.9%) |
| Jun 2007 | - | -$129.57 M(+12.7%) |
| Dec 2006 | -$114.92 M(+15.2%) | -$114.92 M(+7.3%) |
| Jun 2006 | - | -$107.08 M(+7.3%) |
| Dec 2005 | -$99.79 M(+16.3%) | -$99.79 M(+10.0%) |
| Jun 2005 | - | -$90.73 M(+5.8%) |
| Dec 2004 | -$85.78 M(+23.8%) | -$85.78 M(+8.1%) |
| Jun 2004 | - | -$79.37 M |
| Dec 2003 | -$69.30 M | - |
FAQ
- What is XTL Biopharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual retained earnings year-on-year change?
- What is XTL Biopharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly retained earnings year-on-year change?
What is XTL Biopharmaceuticals annual retained earnings?
The current annual retained earnings of XTLB is -$158.25 M
What is the all time high annual retained earnings for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual retained earnings is -$69.30 M
What is XTL Biopharmaceuticals annual retained earnings year-on-year change?
Over the past year, XTLB annual retained earnings has changed by -$1.78 M (-1.14%)
What is XTL Biopharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of XTLB is -$158.77 M
What is the all time high quarterly retained earnings for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly retained earnings is -$79.37 M
What is XTL Biopharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, XTLB quarterly retained earnings has changed by -$1.00 M (-0.64%)